BR9711059A - Utiliza-Æo do efaroxan - Google Patents

Utiliza-Æo do efaroxan

Info

Publication number
BR9711059A
BR9711059A BR9711059A BR9711059A BR9711059A BR 9711059 A BR9711059 A BR 9711059A BR 9711059 A BR9711059 A BR 9711059A BR 9711059 A BR9711059 A BR 9711059A BR 9711059 A BR9711059 A BR 9711059A
Authority
BR
Brazil
Prior art keywords
pct
date feb
efaroxan
sec
pub
Prior art date
Application number
BR9711059A
Other languages
English (en)
Inventor
Marc Marien
Jean-Claude Martel
Francis Colpaert
Trierry Imbert
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of BR9711059A publication Critical patent/BR9711059A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Confectionery (AREA)
BR9711059A 1996-08-12 1997-08-12 Utiliza-Æo do efaroxan BR9711059A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9610118A FR2752163B1 (fr) 1996-08-12 1996-08-12 Utilisation de l'efaroxan pour la fabricaton de medicament destine au traitement de la maladie de huntington
PCT/FR1997/001480 WO1998006393A1 (fr) 1996-08-12 1997-08-12 Utilisation de l'efaroxan pour la fabrication de medicament destine au traitement de la maladie de huntington

Publications (1)

Publication Number Publication Date
BR9711059A true BR9711059A (pt) 1999-08-17

Family

ID=9494997

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9711059A BR9711059A (pt) 1996-08-12 1997-08-12 Utiliza-Æo do efaroxan

Country Status (11)

Country Link
US (1) US6153638A (pt)
EP (1) EP0938311B1 (pt)
JP (1) JP2001501171A (pt)
CN (1) CN1105560C (pt)
AT (1) ATE232098T1 (pt)
AU (1) AU714437B2 (pt)
BR (1) BR9711059A (pt)
CA (1) CA2263366A1 (pt)
DE (1) DE69718928D1 (pt)
FR (1) FR2752163B1 (pt)
WO (1) WO1998006393A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8188126B2 (en) * 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK146787A (da) * 1987-03-23 1988-09-24 Ferrosan Heterocykliske forbindelser, deres fremstilling og anvendelse
EP0451790A1 (de) * 1990-04-12 1991-10-16 Hoechst Aktiengesellschaft 3,5-disubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu deren Herstellung, diese enthaltende Mittel und ihre Verwendung
US5739284A (en) * 1992-10-19 1998-04-14 Brigham And Women's Hospital, Inc. Compositions corresponding to a high-affinity glutamate transporter molecule and methods for making and using same
TW264473B (pt) * 1993-01-06 1995-12-01 Hoffmann La Roche
FR2707166B1 (fr) * 1993-07-09 1995-09-29 Pf Medicament Utilisation de l'efaroxan et de ses dérivés pour la fabrication de médicaments destinés au traitement de maladies neurodégénératives et leur progression .
US5741778A (en) * 1996-03-19 1998-04-21 Amgen Inc. Method for treating Huntington's disease using glial cell line-derived neurotrophic factor (GDNF) protein product

Also Published As

Publication number Publication date
FR2752163B1 (fr) 1998-10-30
ATE232098T1 (de) 2003-02-15
AU714437B2 (en) 2000-01-06
CA2263366A1 (fr) 1998-02-19
AU4120697A (en) 1998-03-06
EP0938311A2 (fr) 1999-09-01
DE69718928D1 (de) 2003-03-13
US6153638A (en) 2000-11-28
FR2752163A1 (fr) 1998-02-13
WO1998006393A1 (fr) 1998-02-19
CN1105560C (zh) 2003-04-16
JP2001501171A (ja) 2001-01-30
EP0938311B1 (fr) 2003-02-05
CN1230113A (zh) 1999-09-29

Similar Documents

Publication Publication Date Title
EA199800667A1 (ru) Новые фенантридины
ES2178754T3 (es) Conservante para la madera para la proteccion posterior.
ES2083595T3 (es) Derivados de indol que inhiben la biosintesis de leucotrienos.
ES2152414T3 (es) Dihidrobenzofuranos.
DK1071422T3 (da) Kombinationer af riluzol og levodopa til behandling af parkinsons sygdom
BG105112A (en) Agents with antidepressive effect
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
DE60127537D1 (de) VERWENDUNG VON 2-(4-ETHOXY-PHENYL)-3-(4-METHANESULFONYL-PHENYL)-PYRAZOLOÄ1,5-bÜPYRIDAZINE ZUR BEHANDLUNG VON NICHTULZERATIVER DYSPEPSIE
DE69610825T2 (de) Zahnbürste
DE59510667D1 (de) Pyridylthioverbindungen zur bekämpfung von helicobacter-bakterien
ATE129865T1 (de) Pfanne aus stahl.
BR9711059A (pt) Utiliza-Æo do efaroxan
FI970330A (fi) Imidatsopyridiini-atsolidinonit
FI953002A0 (fi) Menetelmä kroonisen eturauhastulehduksen hoitamiseksi 17beta-N-monosubstituoiduilla karbamoyyli-4-atsa-5alfa-androst-1-en-3-oneilla
SE9404438D0 (sv) New process
PT100001A (pt) Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos
DE59510674D1 (de) Verwendung von selegilin zur behandlung von epileptischen erkrankungen
SE9501773D0 (sv) New use
ES2136443T3 (es) Limpieza in situ.
ATE176244T1 (de) Prozess zur reinigung von natürlichem lungen- surfactant mittels superkritischer flüssigkeiten

Legal Events

Date Code Title Description
HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: REFERENTE A RPI 1720 DE 23/12/2003

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM O ARTIGO 8O DA LPI.